SRNE News....Key Area

This could be an important area for NASDAQ:SRNE right now. You've got Fibs and major moving averages all converging at the same point. News today:

"Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a presentation on its corporate website to provide an overview of Sorrento’s proprietary mRNA vaccine development program for COVID-19."

The presentation can be viewed at: investors.sorrentotherapeutics.com/events-and-presentations/presentations

Funny to think this was just a penny stock not that long ago:

Sorrento Therapeutics Inc. (SRNE Stock Report) is actually still one of the popular stocks on Robinhood this month. Compared to where it was trading in March, 2020, SRNE stock is trading at levels night and day different this month. In fact, SRNE stock hasn’t been considered a penny stock since the end of June. The range has gone from lows of $1.55 to highs of $19.39 so far.

Quote Source & Read More: Are Penny Stocks Worth It? 5 That Hit It Out Of The Park In 2020
covidplayFibonacci RetracementFundamental AnalysisTechnical IndicatorssorrentotherapeuticsSRNEstocktwitsstocktwits-predictionsTrend Analysisvaccinestocks

Also on:

Disclaimer